Ephedra Interactions Overview

Check For Interactions With Ephedra

Ephedra

Also known as
  • Ephedra distachya
  • Belcho
  • Cao Mahuang
  • Desert Herb
  • Ephedra Sinisa
  • Herbal Ecstasy
  • Indian Jointfir
  • Joint Fir
  • Ma Huang
  • Popotillo
  • Raisin de Mer
  • Sea Grape
  • Teamster's Tea
  • Yellow Astringent
  • Yellow Horse
  • Zhong Mahuang
Ephedra Ephedra, also known as ma huang, is a plant species in the family Ephedraceae, which is native to Asia and parts of North America. It has been used traditionally in herbal medicine for centuries to treat a variety of conditions, including respiratory problems, allergies, and obesity. Ephedra contains a number of active compounds, including ephedrine and pseudoephedrine, which are stimulants that affect the central nervous system. The stimulant compounds in ephedra compounds have been used in a number of over-the-counter and prescription medications, including decongestants and weight loss supplements. While ephedra and related stimulant compounds are still available in a number of over-the-counter medications, such as the inhaler Primatene Mist, and Bronkaid Caplets, it is banned for use in dietary supplements. Ephedra was once an extremely popular ingredient in dietary supplements for weight loss, but it was linked to a number of serious adverse effects, including increased blood pressure, heart palpitations, stroke, and even death. As a result, the use of ephedra and ephedra-containing products were banned or restricted in many countries.
There are 801 drugs known to interact with Ephedra

Drugs that interact with Ephedra

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLCs